How innate lymphoid cells (ILCs) in the thymus and gut become specialized effectors is unclear. The prototypic innate-like gd T cells (Tgd17) are a major source of interleukin-17 (IL-17). We demonstrate that Tgd17 cells are programmed by a gene regulatory network consisting of a quartet of high-mobility group (HMG) box transcription factors, SOX4, SOX13, TCF1, and LEF1, and not by conventional TCR signaling. SOX4 and SOX13 directly regulated the two requisite Tgd17 cell-specific genes, Rorc and Blk, whereas TCF1 and LEF1 countered the SOX proteins and induced genes of alternate effector subsets. The T cell lineage specification factor TCF1 was also indispensable for the generation of IL-22 producing gut NKp46 + ILCs and restrained cytokine production by lymphoid tissue inducer-like effectors. These results indicate that similar gene network architecture programs innate sources of IL-17, independent of anatomical origins.
INTRODUCTION
Innate lymphoid cells (ILCs) and innate-like T cells (ILTC) producing interleukin-17 (IL-17) and IL-22 have emerged as the central players in mucosal immunity (Spits and Di Santo, 2011) . Upon infection or alterations in cellular environments, ILCs lacking clonal antigen receptors and T cells expressing gd TCR rapidly produce effector cytokines and growth factors to promote pathogen clearance and tissue repair (O'Brien et al., 2009; Sonnenberg et al., 2011) . gdTCR + ILTCs, similar to adaptive ab CD4 + T cells, are segregated into effector subsets.
However, unlike ab T effectors, gdTCR + effector subsets can be classified by the germline-encoded TCR chains and they are generated in the thymus (Jensen et al., 2008; Narayan et al., 2012; Ribot et al., 2009 ). More than half of Vg2 TCR + (designated as V2) gd T cells are intrathymically programmed to produce IL-17 (Tgd17) and express RORgt (Rorc), the primary transcription factor (TF) controlling IL-17 and IL-22 expression in all lymphocytes (Ivanov et al., 2006) . The emergent immature (CD24 hi ) gd thymocyte subsets are further distinguished by TF networks that may specify effector fates. Most of these, including the high-mobility group (HMG) TFs SOX4 and SOX13, are expressed highly only at the early effector programming phase, their expression subsiding once effector capacity has been established at the mature (CD24 lo ) stage. Whether this ''early'' wave of TFs dominantly programs ILTC subset function was unknown.
In addition to Tgd17 ILTCs, there are at least four other RORgt + ILTC and ILC subsets producing IL-17 and/or IL-22: abTCR + invariant NKT (Rachitskaya et al., 2008) , lymphoid tissue inducer (LTi)-like (Sawa et al., 2010; Takatori et al., 2009) , natural killer (NK) cell receptor expressing IL-22 producer (NKp46 + NCR22; Luci et al., 2009; Sanos et al., 2009; Satoh-Takayama et al., 2008; Vonarbourg et al., 2010) , and ILC17 cells (Buonocore et al., 2010) , with the latter three subsets primarily localized in the gut associated lymphoid tissues (GALTs). How ILTCs and ILCs are programmed toward distinct effectors is not well understood. In particular, whether they share a unifying genetic blueprint for differentiation distinct from that specifying adaptive helper IL-17 + T helper 17 cells (Th17) is unknown. To answer these questions, we determined the mechanism of innate effector programming of Tgd17 cells and its possible involvement in GALT ILC differentiation. We showed that the HMG TF TCF1 and LEF1, and their interacting partners SOX4 and SOX13, are expressed at particularly high amounts in the precursors of Tgd17 cells (Narayan et al., 2012) . HMG TFs are transcription complex architectural proteins that bind to related sequences in the minor groove of DNA, and their cell-typespecific combinatorial clustering at target genes cooperatively controls transcription (Badis et al., 2009 ). TCF1, the nuclear effector of WNT signaling, is the best characterized HMG TF and is critical for T cell lineage specification downstream of Notch (Germar et al., 2011; Weber et al., 2011) . We show here that the HMG TFs, not conventional TCR signaling, programmed IL-17 production in gd ILTCs. Moreover, TCF1 controlled cytokine production in postnatal GALT ILCs and was absolutely 
RESULTS
To determine whether a common gene network controls innate lymphoid effector differentiation, we first identified genes selectively required to generate V2 Tgd17 cells. Emergent gd ILTC subsets are marked with gene expression profiles predictive of their eventual effector functions upon thymic egress (Narayan et al., 2012) . Hence, the gd T effector subtype-specific core TF networks were candidates for specifying innate effector lineage fate. Tgd17 precursors, immature V2 (immV2, CD24 hi ) thymocytes, express genes encoding three HMG TFs, Sox4, Sox13, and Tcf7 (encoding TCF1) at the highest amounts, whereas the HMG TF Lef1 is expressed at similar amounts relative to other gd cell subsets (Narayan et al., 2012) . Aside from Lef1, the HMG TF expression precedes that of TCR (Melichar et al., 2007; Schilham et al., 1997; Verbeek et al., 1995; Weber et al., 2011; www.immgen.org) . To determine whether this expression pattern programs Tgd17 cell differentiation and function, we examined gd T cell subsets in Sox13 À/À (Melichar et al., 2007) ,
Sox4-deficient, and Tcf7
À/À (Verbeek et al., 1995) mice and determined HMG TF chromatin occupancies in ex vivo Tgd17 precursors.
Sox13 Programs V2 Cell Tgd17 Differentiation
We found that Sox13-deficiency eliminated all V2 Tgd17 cells, whereas other gd effector subsets were largely intact ( Figure 1 ). Sox13 was identified as a gd T cell-specific TF that interacts with TCF1 and LEF1 (Melichar et al., 2007) , potentially modulating their function. Whereas all immature gdTCR + thymocytes express Sox13, Tgd17 precursors express the protein at the highest level (see Figure S1A available online), with its expression rapidly extinguished upon thymic maturation (Narayan et al., 2012 (Narayan et al., 2012) . Fetal and adult RORgt + matV2 thymocytes, the immediate precursors of peripheral Tgd17 cells, were missing ( Figure 1B ; Figure S1D ), while the number of immV2 cells was not significantly altered. The remaining V2 cells in Sox13 À/À mice did not synthesize IL-17 (or IL-17F, data not shown) ex vivo ( Figure 1B ), even after stimulation with the TLR2 ligand, Zymosan ( Figure 1C ). These results demonstrate that the high SOX13 expression in developing immV2 thymocytes is a critical factor in Tgd17 cell differentiation. The loss of V2 Tgd17 cells occurred in both the fetal and adult Sox13 À/À thymus. Fetal-derived Vg4 + (V4) gd T cells are the alternate IL-17 producers (Shibata et al., 2008) . Vg4 gene rearrangements, which predominate in early fetal stages, precede that of Vg2 and the fetal Vg4 chain is paired with the germline encoded Vd1TCR. While V4 Tgd17 cells were negatively impacted in the fetal thymus by the absence of SOX13, these effectors were present in neonatal and adult Sox13 À/À mice ( Figures S1E-S1G ). This result suggests that despite the lineage and functional relatedness (Narayan et al., 2012) , developmental requirements for V2 and V4 Tgd17 cells are distinct. B lymphocyte kinase (BLK) is essential for Tgd17 development (Laird et al., 2010) . Ectopic Sox13 expression induces Blk expression in ab thymocytes (Melichar et al., 2007) and among gd T cells, BLK + cells are the sole source of IL-17 during pathogen challenge (Laird et al., 2010; Narayan et al., 2012) . In Sox13 À/À mice, V2 Tgd17 precursors (immV2 cells) expressing normal amounts of BLK were depleted and the BLK and RORgt coexpressors were specifically absent ( Figure 1D ). Analysis of Rorc Gfp/+ :Sox13 À/À mice showed decreased, but still significant, transcription of Rorc in the mutant immV2 cells ( Figure 1E ). These results suggested that SOX13-regulated BLK expression at the immature stage is critical for Tgd17 cell differentiation. In support of this interpretation, transgenic (Tg) expression of Sox13 in all developing gd cells (Melichar et al., 2007) increased the proportions of BLK + gdTCR + cells, as well as the amount of BLK expression per cell, independent of TCR repertoire (Figure 1F) . Correspondingly, more gd T cells in peripheral tissues produced IL-17 ( Figure 1G ). This enhancement was pronounced for V4 gd T cells (Vg2 À ), whereas high ectopic Sox13 expression was particularly detrimental for the survival of V2 cells that express the highest endogenous amount of Sox13 (Melichar et al., 2007) , confounding their analysis in the gain-of-function model system. The absence of V2 Tgd17 cells in Sox13 À/À mice and the increased IL-17 production from gd T cells by the ectopic expression of SOX13 indicate that SOX13 is necessary for programming IL-17 production in ILTCs.
Sox4
Regulates RORgt Expression and Is Necessary for IL-17-Mediated Skin Inflammation Thymic precursors lacking SOX4 also did not generate V2 Tgd17 ILTCs in vivo (Figure 2 ). SOX4 is expressed highly in T and B cell precursors as well as in immature ab CD4 + CD8 + double-positive (DP) and gd thymocyte subsets (www.immgen. org). SOX4 is a transcriptional activator and was shown to also physically interact with TCF1 and LEF1 (Sinner et al., 2007;  data not shown). We generated T-cell-specific Sox4-deficient (T-Sox4 Figure S1 .
Strikingly, V2 Tgd17 ILTCs were not observed in T-Sox4 À/À mice, whereas other gd effector subsets were present ( Figure 2A ; data not shown (Figure 2A ; data not shown), whereas immV2 cells were present in normal proportions (Figure S2A) and did not exhibit decreased rates of survival or proliferation ( Figure S2B ). Accordingly, the remaining differentiated V2 cells in T-Sox4 Figure S2C) . This loss was nearly absolute, more severe than the decrease observed in Sox13 À/À mice ( Figure 1E ). In contrast, RORgt expression in ab DP thymocytes was unaffected by the loss of SOX4 ( Figure 2C ), indicating that SOX4 is a gd ILTCspecific modulator of RORgt expression. Tgd17 cells have been implicated in the dermal inflammationdriven psoriasis-like disease in mice (Cai et al., 2011; Pantelyushin et al., 2012) . The disease can be induced by the application of the TLR7 ligand Imiquimod (IMQ) to skin. Tgd17 cells residing in the dermis have been shown to be the primary lymphoid responders responsible for the disease. To determine whether SOX4 is necessary to generate pathogenic dermal Tgd17 cells, we first assessed the distribution of gd T cell subsets in the dermis of T-Sox4 À/À mice. V2, but not V4, Tgd17 cells were greatly reduced in T-Sox4 À/À dermal tissues before treatment (Figures S2D and S2E) . After topical application of IMQ for 5 days, we observed significant thickening, scaling, and erythema in WT mice. However, T-Sox4
mice did not show overt inflammation (Figures S2F and S2G) , which was quantified by the adapted Psoriasis Area and Severity Index (PASI) scoring system ( Figure 2D ). The lack of inflammation was correlated with significantly decreased proportions of V2 Tgd17 cells (Figures Figure S2I ; data not shown). V4 LN T cells responded to IMQ, as indicated by an increase in the proportion of IL-17 producers ( Figure S2I ). However, this response, and the persistence of dermal V4 cells in T-Sox4
mice ( Figures S2D and S2E ), was insufficient to precipitate the fulminant inflammatory condition in the skin. In conjunction with previously published reports (Cai et al., 2011; Pantelyushin et al., 2012) , these results indicate that SOX4-dependent V2 Tgd17 cells are the primary ILTCs mediating IMQ-mediated skin inflammation. In addition, the results showed that fetalderived V4 Tgd17 cells, while acutely dependent on SOX13 during gestation, have compensatory mechanisms to bypass the SOX4 requirement and replenish their numbers in peripheral tissues in the absence of either TFs. In contrast, the ''late'' V2 Tgd17 cells are not produced in the absence of Sox4 or Sox13, reinforcing the conclusion that these two ILTC subsets are generated under distinct conditions and are not functionally interchangeable.
TCF1 Restrains IL-17 + Cell Generation
Tcf7 is turned on by Notch signaling to specify the T cell fate (Germar et al., 2011; Weber et al., 2011) . Notch signaling also controls GALT ILC differentiation (Lee et al., 2012; Possot et al., 2011) , raising the possibility that TCF1 is the core regulator of innate effector differentiation. In the absence of TCF1, development of thymic precursors and ab T cells is aberrant (Verbeek et al., 1995) . Although the total gd thymocyte number is not significantly decreased in young Tcf7 À/À mice (Verbeek et al., [Ribot et al., 2009] ) populations, with the latter subset being undetectable in some Tcf7 À/À mice ( Figure 3A ). More than 80% of Tcf7 À/À V2 cells produced IL-17, twice the frequency observed in WT V2 cells, and they were uniformly RORgt + ( Figure 3A) . The bias toward IL-17 production was not V2 cell-specific because the number of thymic mature Vg1.1 + (normally IFN-g + ) cells expressing IL-17 was also increased by >10-fold ( Figure S3C ). This pattern was not observed in Tcrb À/À mice (N.M., data not shown), indicating that the deregulated effector programming is not simply a consequence of the decreased production of ab thymocytes in Tcf7 À/À mice.
In all thymic gd subtypes, the decreased expression of CD27 was already evident at the immature stage ( Figure 3B ). This pattern, along with a relatively normal cell-cycle status of Tcf7 À/À gd thymocytes ( Figure S3D ), suggested that the proclivity of TCF1-deficient gd ILTCs toward the IL-17 effector fate is an early developmental event, not a consequence of altered maintenance of mature effectors. This interpretation was further supported by the LEF1 expression pattern. LEF1 was a discriminatory regulator of gd effectors, as evidenced by its mutually exclusive expression to RORgt in gd thymocytes ( Figure 3C ; Figure 3E ) and the partial and complete loss of LEF1 + subsets in Vg1.1 + and V2 cells, respectively, when TCF1 was absent ( Figures 3C and 3D) , again starting at the immature stage of differentiation ( Figure 3D ). Lef1 expression is primarily controlled by TCF1 (Driskell et al., 2007) . Given the precedent that some TCF1 target gene expression can be inhibited by SOX13 (Marfil et al., 2010; Melichar et al., 2007) , high amounts of SOX13 in immV2 thymocytes may interfere with TCF1-mediated induction of Lef1. Consistent with this, immature gdTCR + thymocytes from Sox13Tg mice expressed significantly lower amounts of LEF1 and CD27 ( Figure S3F ). Taken together, TCF1 is necessary for pan-gd T cell development (Figures S3G and S3H) , and it programs gd T effector subset differentiation, promoting and inhibiting IFN-g and IL-17 production, respectively, whereas SOX4 and SOX13 have the opposite function.
HMG TF Chromatin Occupancy
Fetal and adult immV2 thymocytes share the TF transcriptome ( Figures S4A and S4B ). To determine whether HMG TFs directly regulate the Tgd17 gene network, we examined their chromatin occupancies at three gene loci (Blk, Rorc, and Il17a) (Narayan et al., 2012) . Accordingly, the Blk and Rorc loci were selectively enriched for active H3K4me3 (and acetylated H3, data not shown) modifications in immVg2 + cells.
Conversely, the Rorc locus was repressed in immVg2 À cells as indicated by H3K27me3 markings ( Figure S4C ). In contrast, Il17a was decorated exclusively with repressive H3K27me3 chromatin marks in the immature gd thymocytes, consistent with its restricted expression in mature gd thymocytes (Narayan et al., 2012) . These results indicate that the distinct effector gene expression profiles of immature gd cell subsets are foremost regulated at the chromatin level. Next, we determined HMG TF occupancy of Blk, Rorc, and Il17a loci. SOX13 was localized to the Blk and Rorc loci in immature Vg2
+ , but not Vg2 À , thymocytes (Figure 4) . The low signals in Vg2-thymocytes can be accounted for by low SOX13 protein expression in the cells ( Figure S1A ). Although SOX4 was detected at all four loci assessed in gd thymocytes, only the docking at the Rorc loci was conserved in ab Th17 cells. Moreover, SOX4 was particularly enriched at the Region 2 (R2) near the transcription start site dedicated for RORgt production in Vg2 + thymocytes (Ruan et al., 2011) . These results supported the above finding (Figure 2 ) that SOX4 is an essential regulator of Rorc expression in Tgd17 cells. Immature Vg2 + and Vg2 À thymocytes, the immediate precursors of mature thymic effectors, were compared to in vitro differentiated control Th1 and Th17 CD4 ab T cells. Analysis of mature gd thymocytes was not possible due to their low numbers in mice. Graphs show quantitative PCR detection for relative enrichment of target DNA sequences from ChIP using Abs to indicated TF and control IgG ( Figure S4 ). The regions examined are described in Figure S4 legend. Quantitative real-time PCR data are plotted as average percentage (%) of input ± SD from two independent experiments. Binding of the TFs to TCF consensus sequences at the control MyoG promoter was undetectable in T cells (data not shown). See also Figure S4 .
TCF1 was enriched at the Blk and Rorc loci in immature Vg2 + cells, but not in immature Vg2 À cells. TCF1 and LEF1
occupancy at the Il17a locus exhibited distinct modality with TCF1 preferentially enriched at the intronic R2, previously shown to be a docking region in ab T cells , in both thymic subsets and LEF1 at the promoter upstream R1, particularly in immature Vg2 À thymocytes. Consistent with the TCF1 chromatin occupancy in precursor cells (Weber et al., 2011) , TCF1 was found docked onto the Gata3 locus in gd thymocyte subsets, but LEF1 was not. LEF1 was associated with the Blk locus in Vg2 + thymocytes, presumably in the RORgt À fraction, based on the mutually exclusive expression of RORgt and LEF1 in V2 thymocytes ( Figure 3C ). That LEF1 docking at the Blk locus is neutral to suppressive for transcription is supported by a selective enrichment at the locus in ab Th17 cells that do not express Blk. Figure S5A ), establishing ITK as a key signal integrator of gdTCR signaling. In the absence of ITK, the transcriptomes of immV2 thymocytes converged with other gd cell subsets, as indicated by principal component analysis (PCA, Figure 5A ) that clusters related populations based on the major components of gene expression variability. ITK signaling was responsible for $90% of the unique immV2 thymocyte transcriptome ( Figure S5B ). However, the characteristic TF profile of immV2 cells was mostly insulated from change when ITK was absent, as shown by hierarchical clustering ( Figure 5B ), correlating with the relatively normal generation of Tgd17 cells in Itk À/À mice ( Figure S5C ). These results demonstrate that while Vg2TCR-ITK signaling is central to the establishment of distinct transcriptomes of gd subsets it is not responsible for the wiring of gd effector subset-specific TF networks at the immature stage. Together, these results indicate that the conventional TCR signaling pathways so far implicated in adaptive Th17 differentiation do not dominantly specify the Tgd17 cell fate. To directly assess the role of the gdTCR in Tgd17 cell differentiation, gd T effector development was tracked in Vg2 TCR Tg mice where nearly all gd T cells express the identical Vg2 TCR chain (Kang et al., 1998 Figure 5C ). These results indicated that specific Vg2 TCR signaling per se is not the dominant determinant of effector lineage specification. If the TCR signaling alone cannot specify ILTC effector fates, an alternate possibility was that distinct effector programs are preset at different developmental stages. To test whether T cell developmental intermediates possess unique effector generative capacity, we compared the ability of the early c-Kit (CD117) + T progenitors (ETP) versus the late c-Kit neg DN3 precursors to generate Tgd17 effectors. ETPs (fetal and adult) generated CCR6 + CD27 À Tgd17 V2 cells in the standard OP9-DL1 culture system ( Figure 5D ). However, no significant generation of CCR6 + CD27 À V2 cells was detectable from DN3
precursors. Further, the late precursors were markedly biased to produce V1 and V2 CD27 + gd cells ( Figure S5D ; data not shown). Together, these findings suggest that the maturational state of the precursors, and not TCR signaling alone, is a key determinant of Tgd17 effector lineage specification.
TCF1 Is Necessary for GALT ILC Differentiation
One implication of the dominance of the HMG TF network in ILTC effector differentiation was that a similar regulatory gene network may operate to generate GALT ILCs that lack clonal antigen receptors. GALT ILCs express several HMG TFs at the messenger RNA level. These include Tcf7, Sox4, and Tox (Aliahmad et al., 2010), though not Sox13 (Reynders et al., 2011 ; data not shown). To determine whether HMG TF networks control innate effector differentiation extrathymically, we first established the ILC subset-specific expression pattern of TCF1 and LEF1 proteins and Axin2, a canonical TCF1-WNT signaling target that can serve as a reporter of TCF1 as a transcriptional activator (Lustig et al., 2002 Figure S6A ), whereas <10% of the RORgt Figure 6C ; data not shown). LTi-like ILCs are CCR6 + CD25 + (Sawa et al., 2010; Vonarbourg et al., 2010) and the frequency of the CCR6 + fraction was elevated, a trend that was already evident in Tcf7 +/À heterozygotes ( Figure 6D ). However, Tcf7 À/À LTi-like
ILCs lost CD25 expression, most likely indicating that as in T cell precursors (Weber et al., 2011) , TCF1 may be a positive regulator of Cd25 transcription in ILCs.
In 3-to 4-week-old Tcf7 À/À mice, the number of RORgt + ILCs was reduced to one third of normal in the mLN, whereas IL-7R
À RORgt neg-lo fraction was decreased to 10% of normal ( Figure 6E ). As in neonates, NKp46 + ILCs were specifically depleted (Figures 6E and 6F ; Figure S6C ). These results show that TCF1 is absolutely required for NCR22 cell generation, whereas LTi-like ILC production per se appears less dependent on TCF1. During Tgd17 differentiation, TCF1 dampened effector capacity (Figure 3 ). To determine whether TCF1 functions similarly in differentiated ILCs, we assessed the effector capacity of Tcf7 À/À ILCs. All RORgt + ILCs in Tcf7 À/À mice expressed higher amounts of RORgt per cell ( Figure 6G ) and were capable of enhanced IL-17 production ( Figure 6H , top row). Upon activation with TLR2 agonist Zymosan, IL-17 and IL-22 production from Tcf7 À/À LTi-like ILCs was significantly elevated ( Figure 6H ; Figure S6C ). Thus, as in gd ILTC development, TCF1 has a dual function in ILC development, coordinating normal gene induction to ensure proper differentiation of ILC subsets and controlling effector function by restraining RORgt expression and IL-17 and IL-22 production.
DISCUSSION
We showed that dermal SOX13 and SOX4-dependent V2 Tgd17 cells are the primary innate lymphoid mediators of psoriasis-like disease in C57BL/6 mice and they develop in the thymus under the control of a HMG TF regulatory network. Adaptive Th17 cell differentiation in peripheral tissues requires TCR signaling and its downstream targets ITK (Gomez-Rodriguez et al., 2009) and IRF4 (Brü stle et al., 2007) , the inflammatory cytokine IL-6 and its signal mediator STAT3 (Zhou et al., 2007) , as well as TGFb-activated SMAD2 (Malhotra et al., 2010) . None of these factors are essential for Tgd17 ILTC development in the thymus Malhotra et al., 2010; Powolny-Budnicka et al., 2011) . Instead, a complex network of HMG TFs cooperatively controls thymic ILTC differentiation by direct regulation of key genes involved in effector function. Among them, SOX4 and SOX13 are the central positive regulators of Tgd17 differentiation, by primarily inducing RORgt and BLK, respectively, and potentially localizing their interacting partner TCF1 to select chromatin sites. Given that HMG TFs operate in conjunction with cofactors, a detailed understanding of target gene-specific function of SOX4 and SOX13 awaits the full characterization of transcriptional complexes assembled by each factor. During early fetal dendritic epidermal gd T cell (Vg3 + ) differentiation, cell surface SKINT signaling normally suppresses Rorc and Sox13 expression to block IL-17 production (Turchinovich and Hayday, 2011) , underscoring the importance of SOX13 in positively enforcing the IL-17 effector fate that must be circumvented to generate alternate innate effector cells in the fetus. SOX13 regulates several key factors of V2 Tgd17 cell differentiation, including Blk, Rorc, and Etv5 (K.E.S., data not shown). The exclusion of LEF1 from developing Tgd17 cells is also likely to be established by SOX13, as suggested by the diminished Lef1 expression in Sox13Tg mice. Although published studies to date support protein-protein interactions as the main regulatory mode of SOX13-TCF1 functions, it remains possible that each can impact chromatin occupancy of the other. For instance, the loss of TCF1 may result in more precursors with SOX13 bound to the Rorc locus, thereby leading to the enhanced generation of Tgd17 cells. However, Tcf7 À/À gd cells do not express LEF1, and the loss of LEF1-dependent effector developmental potential may also indirectly enhance Tgd17 cell production. A systemic approach that can simultaneously track all relevant HMG TFs during Tgd17 differentiation from thymic precursors will be necessary to define the rules governing functional connectivities of HMG TFs. The mechanism by which the temporally disparate emergence of gd effector subtypes is linked to specific TCRg and d repertoire remains to be determined. We have identified ITK as a discriminatory signal mediator of TCR that is required for the molecular divergence of V2 cells from other gd cell subsets. Previously, it has been shown that some IL-17 + Vg2 + T cells can be generated in the absence of ligand recognition, whereas TCR triggering led to the capacity to produce IFN-g (Jensen et al., 2008) . In vitro assays, however, showed that the cell surface expression of Vg2TCR itself is uniquely able to trigger signaling, akin to the pre-TCR signaling that generates ab DP cells. Given the substantial, but constrained, alterations of V2 cells in Itk À/À mice, we propose that the Vg2TCR-ITK signaling constitutes a developmental checkpoint related to the b selection for ab thymocytes but that this tonic signaling alone does not regulate the TF transcriptome that programs the Tgd17 effectors. Published data (Jensen et al., 2008; Ribot et al., 2009; Turchinovich and Hayday, 2011) and our results from the in vitro cultures and TCRg Tg mice indicate at least two other factors that can contribute to the observed correlation between TCR repertoire and effector function: developmental timing and limiting permissive niches. In the OP9 culture system, DN3 cells and their progenies cannot generate Tgd17 cells, indicating a developmental stage-specific gene program, perhaps linked to an ordered Tcrgv gene rearrangement process. However, the enforced expression of Vg2TCR does not enhance the number of Tgd17 cells generated in vivo, indicating that Vg2TCR-specific signals alone cannot dictate effector fate and that there exists a limit to the number of Tgd17 cells that can be produced regardless of the TCR repertoire.
Recently, it has been concluded that most Tgd17 cells are generated during gestation (Haas et al., 2012) . Although this can account for the correlation for V4 cells, whether V2 Tgd17 cells also originate exclusively during gestation remains to be clarified. The requirements for SOX4 and SOX13 in the generation of V2 and V4 Tgd17 cells are distinct, with V2 Tgd17 cells showing an absolute dependence, whereas V4 Tgd17 cells are mostly dependent on SOX13, but even here only the fetal thymic cellularity was significantly impacted by the loss of Sox13. These distinct developmental requirements between V2 and V4 cells are observed despite their overall molecular similarity at the gene expression level (Narayan et al., 2012) , suggesting T cellextrinsic environmental signals differentially affecting the early (Vg4 + ) versus late (Vg2 + ) Tgd17 cell development. The high Tcf7 expression is a unifying feature of developing thymocytes and GALT ILCs. Notch signaling has been shown to directly induce Tcf7 transcription (Germar et al., 2011; Weber et al., 2011) . On the basis of the known targets of TCF1 in T cells and their precursors, TCF1 may directly regulate the expression of several markers of GALT ILCs, including Id2 (Germar et al., 2011; Rockman et al., 2001) , Il7r (Germar et al., 2011) , Cd4 (Huang et al., 2006) , and Cd25 (Weber et al., 2011) . For ILCs, Tcf7-deficiency led to the selective loss of NCR22 cells that have been shown to be most dependent on Notch signaling for development (Lee et al., 2012 (Felices et al., 2009) , and Tcf7 À/À mice (Verbeek et al., 1995) were previously described. Sox4 fl/fl mice were generated by V. Lefebvre (Penzo-Mé ndez et al., 2007) and crossed to CD2p-CreTg mice. All mice were housed in a specific pathogen-free barrier facility and experiments performed were approved by the IACUC.
Flow Cytometry
Antibodies (Abs) used are detailed in Supplemental Information. Data was acquired on a BD LSRII cytometer and was analyzed by using FlowJo (Treestar).
Ex Vivo Stimulation, Zymosan Activation, and OP9 Culture Freshly isolated thymic and LN cells were cultured (2 3 10 6 /well) with PMA (10 ng/ml) and Ionomycin (1 mg/ml) for 4 hr at 37 C, with Golgi Stop and Golgi Plug (BD Biosciences) added after 1 hr. After stimulation, cells were stained for cell surface markers and intracellular cytokine production by using the Cytofix/ Cytoperm kit (BD Biosciences). To activate innate effectors, we injected mice intraperitoneally with Zymosan (Sigma) in PBS (6 mg/mouse). Four hrs postinjection, lymphocytes were isolated from the mLN and spleens. Cells were stimulated with PMA/Iono and intracellular staining for IL-22 and IL-17 in gd ILTCs and ILCs was performed. Intestinal LP lymphocytes from 10-day-old mice were isolated as described (Qiu et al., 2012 À ) cells were plated onto OP9-DL1 monolayers (J. C. ZunigaPflucker) at various concentrations in aMEM media containing 20% FBS (GIBCO), 1 ng/ml IL-7 (R&D Systems), and 5 ng/ml Flt3L (R&D Systems). After 5-12 days of culture, cells were analyzed by flow cytometry.
Psoriasis Induction
Aldara (5% Imiquimod, 3M Pharmaceuticals) or control vehicle cream was applied daily for five days on the back and ear. The disease severity in mice was scored by a modified PASI normally used to rank human psoriasis severity (Fredriksson and Pettersson, 1978) . The scale thickness and erythema were scored from 0 to 4 (slight, moderate, severe, very severe), and the total area of the inflammation covering the back was scored from 0 to 6 (0%, 10%-29%, 30%-49%, 50%-69%, 70%-89%, 90%-100%). The scores for the scales and erythema were added and multiplied by the score for the body area to obtain the total score ranging from 0 (no disease) to 48. Dermal cells were obtained according to a published protocol (Suffia et al., 2005) .
Microarray Analysis
Samples were processed and analyzed according to the standard operating protocol of the Immunological Genome Project (www.immgen.org; Supplemental Information); GEO:GSE15907. 
Chromatin Immunoprecipitation Assay

